Clinical Research Directory
Browse clinical research sites, groups, and studies.
Trial of Maternal Oxygen for Fetal Left Heart Hypoplasia
Sponsor: Shaine Morris
Summary
The purpose of this study is to determine if maternal hyperoxygenation is an effective treatment for fetal left heart hypoplasia versus room air (placebo). This will be determined by measuring how well a baby's heart valves and their surrounding tissue are growing and functioning. In addition the investigators will examine brain growth using fetal ultrasound and MRI, and MRI of the child's brain after they are born to determine if there is greater neonatal brain maturity or mothers receiving oxygen compared to fetuses of mothers not receiving oxygen. Of note, the trial was initially randomized. However, due to low sample size and hesitation about randomization, the trial was converted to an open label study, allowing families opting for oxygen therapy to be in the intervention arm.
Official title: A Pilot Randomized Controlled Trial of Maternal Oxygen Therapy for Fetal Left Heart Hypoplasia
Key Details
Gender
FEMALE
Age Range
14 Years - 60 Years
Study Type
INTERVENTIONAL
Enrollment
12
Start Date
2015-09
Completion Date
2027-07
Last Updated
2023-08-14
Healthy Volunteers
No
Conditions
Interventions
Oxygen
The intervention arm (Oxygen Group) will receive oxygen via nasal cannula at a rate of 4L of FiO2 93-100% from an oxygen concentrator up to 24 hours daily
Locations (1)
Texas Children's Hospital
Houston, Texas, United States